Suppliers / JNTL Consumer Health (France) S.A.S

JNTL Consumer Health (France) S.A.S

France Updated 9 July 2026

JNTL Consumer Health (France) S.A.S is a finished-dose manufacturer based in France. It appears in 297 regulatory filings across 7 regulators, without an active US DMF or CEP on file. Its filings concentrate with MEDSAFE (NZ), SWISSMEDIC (CH) and EMA. Its GMP standing is certified by ANSM (FR), EMA and US FDA. Its most recent recorded inspection, by US FDA, closed on 14 February 2025 as VAI.

0
active US DMFs
0
valid CEPs
8
registered plants 1 with an FDA FEI number
297
filings across 7 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
3 of 3 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 14 February 2025 VAI US FDA
  • 7 May 2021 VAI US FDA
  • 23 January 2015 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Val-De-Reuil, United Arab Emirates Not on file
Risch, Switzerland Not on file
Val-De-Reuil, France Not on file
France, France 3002707994
Val De Reuil, France Not on file
Val-De-Reuil, France Not on file

2 further sites are on record.

Filings and GMP by regulator

Regulator Filings GMP certificates
MEDSAFE (NZ) 99 None
SWISSMEDIC (CH) 59 None
EMA 56 1
AEMPS (ES) 44 None
INFARMED (PT) 35 None
EDE (AE) 3 None
ANSM (FR) None 3
US FDA None 1

Scale

Year Revenue Exports Destinations
2024 $88.0M Not reported Not reported

Export figures are customs aggregates. We do not publish the identity of any buyer. Revenue shown in US dollars, converted from the reported currency.

Comparing suppliers?

Choose your molecules and target markets. JNTL Consumer Health (France) S.A.S comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 14 February 2025.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Company filings
Revenue as reported